Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Digestive Diseases and Sciences
|
July 16, 2016
Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis
Stefano Guandalini, Namita Tundia, Roopal Thakkar, et al.
Journal of Clinical Lipidology
|
February 5, 2011
Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study
William Insull, Jan N Basile, Anthony N Vo, et al.
Journal of Crohn'S & Colitis
|
May 31, 2014
Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease
Mamoru Watanabe, Toshifumi Hibi, Nael M Mostafa, et al.
Journal of Crohn'S & Colitis
|
March 23, 2013
Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials
William J Sandborn, Jean-Frederic Colombel, Julian Panés, et al.
Clinical Drug Investigation
|
March 24, 2009
Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy
Ariane K Kawata, Dennis A Revicki, Roopal Thakkar, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry
Edward V Loftus, Walter Reinisch, Remo Panaccione, et al.
European Journal of Heart Failure
|
January 23, 2009
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE
Alexandre Mebazaa, Markku S Nieminen, Gerasimos S Filippatos, et al.
JAMA
|
May 3, 2007
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial
Alexandre Mebazaa, Markku S Nieminen, Milton Packer, et al.
Journal of Gastroenterology
|
April 14, 2017
Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.
Journal of Gastroenterology
|
March 22, 2017
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Digestive Diseases and Sciences
|
July 16, 2016
Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis
Stefano Guandalini, Namita Tundia, Roopal Thakkar, et al.
Journal of Clinical Lipidology
|
February 5, 2011
Efficacy and safety of combination therapy with niacin extended-release and simvastatin versus atorvastatin in patients with dyslipidemia: The SUPREME Study
William Insull, Jan N Basile, Anthony N Vo, et al.
Journal of Crohn'S & Colitis
|
May 31, 2014
Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease
Mamoru Watanabe, Toshifumi Hibi, Nael M Mostafa, et al.
Journal of Crohn'S & Colitis
|
March 23, 2013
Exploring the use of adalimumab for patients with moderate Crohn's disease: subanalyses from induction and maintenance trials
William J Sandborn, Jean-Frederic Colombel, Julian Panés, et al.
Clinical Drug Investigation
|
March 24, 2009
Flushing ASsessment Tool (FAST): psychometric properties of a new measure assessing flushing symptoms and clinical impact of niacin therapy
Ariane K Kawata, Dennis A Revicki, Roopal Thakkar, et al.
Inflammatory Bowel Diseases
|
February 13, 2019
Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry
Edward V Loftus, Walter Reinisch, Remo Panaccione, et al.
European Journal of Heart Failure
|
January 23, 2009
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE
Alexandre Mebazaa, Markku S Nieminen, Gerasimos S Filippatos, et al.
JAMA
|
May 3, 2007
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial
Alexandre Mebazaa, Markku S Nieminen, Milton Packer, et al.
Journal of Gastroenterology
|
April 14, 2017
Erratum to: Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.
Journal of Gastroenterology
|
March 22, 2017
Four-year maintenance treatment with adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki, Satoshi Motoya, Hiroyuki Hanai, et al.
Page
of 2